You just read:

Genzyme Corporation Pays $5.885 Million To Resolve False Claims Act Allegations; Judgment Involving Cases Against Nine Other Pharmaceutical Manufacturers Certified As Final Judgment, Allowing Appeal

News provided by

Berger & Montague, P.C.

May 05, 2017, 12:02 ET